Fortem Financial Group LLC Acquires 117 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fortem Financial Group LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 16.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 818 shares of the healthcare conglomerate’s stock after buying an additional 117 shares during the period. Fortem Financial Group LLC’s holdings in UnitedHealth Group were worth $414,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Hanlon Investment Management Inc. acquired a new position in shares of UnitedHealth Group during the second quarter worth $200,000. Parcion Private Wealth LLC raised its stake in UnitedHealth Group by 22.6% in the second quarter. Parcion Private Wealth LLC now owns 1,500 shares of the healthcare conglomerate’s stock valued at $764,000 after buying an additional 277 shares during the last quarter. Norden Group LLC grew its stake in shares of UnitedHealth Group by 15.6% during the second quarter. Norden Group LLC now owns 6,080 shares of the healthcare conglomerate’s stock worth $3,097,000 after acquiring an additional 820 shares during the last quarter. Umpqua Bank raised its position in shares of UnitedHealth Group by 3.5% in the 2nd quarter. Umpqua Bank now owns 5,412 shares of the healthcare conglomerate’s stock valued at $2,756,000 after purchasing an additional 184 shares during the last quarter. Finally, Strategic Financial Concepts LLC grew its position in UnitedHealth Group by 43,843.0% during the 2nd quarter. Strategic Financial Concepts LLC now owns 232,019 shares of the healthcare conglomerate’s stock worth $118,158,000 after purchasing an additional 231,491 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded down $2.40 during mid-day trading on Monday, reaching $510.60. 2,718,461 shares of the stock traded hands, compared to its average volume of 3,281,867. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business has a 50-day moving average of $559.83 and a 200 day moving average of $561.31. The stock has a market capitalization of $469.90 billion, a PE ratio of 33.26, a PEG ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the firm earned $6.56 earnings per share. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday. Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. KeyCorp began coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Finally, Oppenheimer increased their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $627.58.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.